Resolute Capital Asset Partners LLC Aura Biosciences, Inc. Transaction History
Resolute Capital Asset Partners LLC
- $165 Million
- Q3 2025
A detailed history of Resolute Capital Asset Partners LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Resolute Capital Asset Partners LLC holds 91,006 shares of AURA stock, worth $503,263. This represents 0.34% of its overall portfolio holdings.
Number of Shares
91,006
Previous 91,006
-0.0%
Holding current value
$503,263
Previous $569,000
1.23%
% of portfolio
0.34%
Previous 0.32%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
106Shares Held
52.1MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$38.3 Million66.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$28.2 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$27 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$25.5 Million1.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$24.2 Million0.81% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $162M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...